Literature DB >> 18814897

Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop.

Elcio Leal1, Wilson P Silva, Maria C Sucupira, L Mário Janini, Ricardo S Diaz.   

Abstract

One of most intriguing features of the HIV-1 subtype B epidemic in Brazil is the high frequency of isolates exhibiting tryptophan (W) in the tetramer (GWGR) at the tip of the V3 loop. We observed that the frequencies of glutamic and aspartic acids at site 25 of the V3 loop are quite distinct in GWGR isolates compared with viruses with other tetramers. The basic amino acids at sites 11 and 25 of V3 are strongly linked with CCR5-to-CXCR4 coreceptor shift. We therefore predicted phenotype usage and found that GWGR isolates are exclusively CCR5-using. Further evidence of this came from intrahost sequences, where basic amino acid substitutions at sites 11 and 25 emerged only in isolates presenting a tryptophan-to-glycine replacement at the tetramer of the V3. In addition, modeled 3D-structures of the V3 loop of GWGR and GGGR in intrahost viruses differ essentially in the binding region of the coreceptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18814897     DOI: 10.1016/j.virol.2008.08.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil.

Authors:  Fernando Lucas Melo; Leda Fátima Jamal; Paolo Marinho de Andrade Zanotto
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-16       Impact factor: 2.205

2.  Diversity of HIV-1 subtype B: implications to the origin of BF recombinants.

Authors:  Elcio Leal; Fabiola E Villanova
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

3.  Homogenous HIV-1 subtype B quasispecies in Brazilian men and women recently infected via heterosexual transmission.

Authors:  Nancy Lima Gouveia; Michelle Camargo; Marcos Montani Caseiro; Luiz Mario Ramos Janini; Maria Cecilia Araripe Sucupira; Ricardo Sobhie Diaz
Journal:  Virus Genes       Date:  2014-02-14       Impact factor: 2.332

4.  Relaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell counts.

Authors:  Élcio Leal; Jorge Casseb; Michael Hendry; Michael P Busch; Ricardo Sobhie Diaz
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

5.  Detection of the B"-GWGR variant in the southernmost region of Brazil: unveiling the complexity of the human immunodeficiency virus-1 subtype B epidemic.

Authors:  Dennis Maletich Junqueira; Rúbia Marília de Medeiros; Thaysse Cristina Neiva Ferreira Leite; Monick Lindenmeyer Guimarães; Tiago Gräf; Aguinaldo Roberto Pinto; Sabrina Esteves de Matos Almeida
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-09       Impact factor: 2.743

6.  Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.

Authors:  Kledoaldo Lima; Élcio de Souza Leal; Ana Maria Salustiano Cavalcanti; Daniela Medeiros Salustiano; Luzidalva Barbosa de Medeiros; Sirleide Pereira da Silva; Heloísa Ramos Lacerda
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

7.  The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use.

Authors:  Ricardo Sobhie Diaz; Lilian A Inocêncio; Maria Cecilia Araripe Sucupira; Anderson Alvarenga Pereira; James Hunter; João Eduardo Ferreira; Luciano V Araújo; Denise F C Souza; Ester Cerdeira Sabino
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

8.  Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B' env molecular clones derived from infections in China.

Authors:  Hui Xie; Jianhui Nie; Qingqing Chen; Weijin Huang; Youchun Wang
Journal:  Emerg Microbes Infect       Date:  2018-05-16       Impact factor: 7.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.